GC022 CAR-T cell immunotherapy

· Hebei Yanda Ludaopei Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GC022 CAR-T cell immunotherapy, covering 2019-01-31 to 2019-01-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GC022 CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL [EARLY_Phase 1]